Plain-English translation of NCT07451522 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a newer medication called can relieve pain as well as morphine in the hours right after heart bypass surgery. Researchers will compare how well each medication reduces pain and monitor how your body responds to each one.
After heart bypass surgery, patients experience significant pain that needs to be treated quickly and effectively. This trial is exploring whether this medication could be an alternative to morphine, potentially offering better pain control or fewer side effects for heart surgery patients.
You likely qualify if…
You likely don't qualify if…
You will have heart bypass surgery as planned. In the first 24 hours after your surgery, if your pain rating exceeds a certain level, you will receive a single injection of either morphine or the new medication (tafalgin), depending on which group you're randomly assigned to. Researchers will measure your pain relief using a simple pain scale, and they will monitor your heart function and blood oxygen levels to see how your body responds.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
Russia